Renjun Pei

Title: Renjun Pei: Innovator in Selective Capture and Drug Release Technologies

Introduction

Renjun Pei is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative techniques for selective capture and release of analytes. With a total of 2 patents to his name, Pei's work is paving the way for advancements in drug delivery systems.

Latest Patents

Pei's latest patents include groundbreaking technologies. The first patent focuses on the selective capture and release of analytes. This invention describes techniques and components for minimally invasive procedures, utilizing aptamers that bind selectively to specific analytes. The aptamer is functionalized on various solid phases, allowing for efficient binding and subsequent release of the analyte through controlled temperature settings.

The second patent involves aptamer-mediated drug release. This innovation discloses aptamer/drug conjugate complexes that can inducibly release drugs when triggered by a specific compound. One example includes an aptamer/insulin conjugate complex, which allows for the release of insulin through an innocuous trigger, such as quinine.

Career Highlights

Renjun Pei is affiliated with Columbia University, where he continues to advance his research in biotechnology. His work has garnered attention for its potential applications in medical treatments and diagnostics.

Collaborations

Pei has collaborated with esteemed colleagues, including Milan N Stojanovic and Jingyue Ju. These partnerships have further enriched his research and contributed to the development of innovative solutions in the field.

Conclusion

Renjun Pei's contributions to selective capture and drug release technologies highlight his role as a leading inventor in biotechnology. His patents reflect a commitment to advancing medical science and improving patient care through innovative solutions.